This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Esteve Pharmaceuticals, S.a.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Ariadna Fernandez-Donis: Innovator in Pain Management
Introduction
Ariadna Fernandez-Donis is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at pain management. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving therapeutic options.
Latest Patents
Ariadna holds a patent for "Homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having multimodal activity against pain." This invention relates to compounds that exhibit dual pharmacological activity towards both the αδ subunit of the voltage-gated calcium channel and the sigma-1 (σ1) receptor. The patent outlines processes for preparing these compounds, pharmaceutical compositions that include them, and their therapeutic applications, particularly for treating pain.
Career Highlights
Ariadna is currently associated with Esteve Pharmaceuticals, S.A., where she continues to advance her research and development efforts. Her work is characterized by a commitment to finding effective solutions for pain management, which is a critical area in medical science.
Collaborations
Ariadna collaborates with esteemed colleagues such as Carmen Almansa-Rosales and José-Luís Díaz-Fernández. These partnerships enhance her research capabilities and contribute to the innovative environment at Esteve Pharmaceuticals.
Conclusion
Ariadna Fernandez-Donis exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to pain management through her patented inventions highlight her role as a key figure in advancing therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
